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Summary: The nature of changes in the lipid profile caused by an acute infection is controversial. The aims of the
present study were to study the changes in plasma lipids and lipoproteins in community-acquired pneumonia, to
determine whether these changes differ according to the aetiologica/agents, and finally to observe the behaviour of
these lipoproteins six months later. Sixty patients, aged between 18 and 87 years, admitted during the period
September 1992 and April 1993 with suspected community-acquired pneumonia, were included in the study. Fifty-
three of the patients completed the 15-day follow-up investigation, and 37 remained available for study for up to
6 months. On admission and at 15 and 180 days, analyses were carried out for total cholesterol, HDL cholesterol,
apolipoproteins A! and B, triacylglycerols and transaminases. Studenfs t test for parametric variables was used for
statistical analysis, and the Mann-Whitney test for non-parametric variables. The concentrations of total cholesterol
[4.2 ±1.0 vs 5.5 ± 1.3 mmol/1), HDL cholesterol (0.9 ± 0.4 vs 1.2 ± 0.3 mmol/1), apolipoprotein A, (0.80 ± 0.25
i vs 1.15 ± 0.28 g/1) and apolipoprotein B (0.77 ± 0.28 vs 0.95 ± 0.28 g/1) showed significantly lower values during
1; die acute infectious process. These analyte concentrations became stable after 15 days with the exception of HDL
• cholesterol which continued to increase until 6 months (1.2 ± 0.3 vs 1.3 ± 0.3 mmol/1, p < 0.01). Patients with
: non-viral atypical pneumonia showed, on admission, higher triacylglycerol values (1.8 ± 0.8 vs 1.3 ± 0.9 mmol/1,
p < 0.01) and lower HDL cholesterol values (0.6 ± 0.3 vs 1.0 ± 0.4 mmol/1, p < 0.03). Values of aspartate amino-
transferase (112 ± 117 vs 23 ± 11 U/l, p < 0.001), alanine aminotransferase (127 ± 141 vs 24 ± 16U/1, p < 0.02)
r and γ-glutamyl transferase (113±158vs33± 25U/1, p < 0.03) were higher in the subgroup of non-viral atypi-
cal pneumonia.
i In conclusion, patients with community-acquired pneumonia present a significant decline in total cholesterol,
HDL cholesterol and apolipoprotein AI and B concentrations. Lower concentrations of HDL cholesterol are
ι maintained up 15 days. Patients with non-viral atypical pneumonia present on admission significantly higher
j triacylglycerol and lower HDL cholesterol values. Those with non-viral atypical pneumonia also present higher
! transaminase values.
! Introduction whether the changes differ according to the aetiological
'' ^ „ „ . . . , - , , - agents, and to study the behaviour of these 6 months, The effect of certain clinical, chemical and environmen-i later.
• tal situations on the lipid profile is well known (1—5).
! However, the effects of infectious processes on the lipid
j profile are controversial While some studies have sig- Materia, 0nd Methods
i nailed an increase in. triacylglycerols and a decrease in
the concentrations of total cholesterol and HDL choles- Samples
ι terol, others have felled to demonstrate changes in serum Sixty seven patients, aged between 18 and 87 years, admitted to
i lipid concentrations (4-8). ourhosPital during!he period SePteraber I992 and APriI 1993 ™*' r ^ ' suspected community-acquired pneumonia, were included in the
! The aim of our investigation was to study the changes V?*?*1·™? diagnosis of pneumoo« was made according to the
. . .° . . criteria of Fang et al. (9) which includes the presence of a pulmo-
j in plasma lipids and lipoproteins of patients with com- nary consolidation in chest radiography, together with the presence
j munity-acquired pneumonia, in order to determine of a major criterion (cough, sputum production, body temperature
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> 37.8 °C) or two minor criteria (pleuritic chest pain, dyspnea,
pulmonary consolidation by examination, leukocytosis > 12
• 109/1). At a later stage seven patients were excluded from the
study for various reasons (2 tumours, 2 tuberculosis and 3 asthmat-
ics with a mucus plug). Fifty-three of the patients completed the
protocol at 15 days, 4 patients dropped out and another 3 died.
During the 6-month follow up 6 of the patients died and another
10 were lost due to various causes. Thus a final total of 37 patients
completed the study. The clinical characteristics and lipid concen-
trations at presentation of those who died or were lost during the
study were similar to the rest of the patient population.
Diagnosis
The diagnosis was definite in the presence of:
a) positive cultures in blood, pleura fluid or lung;
b) isolation of Pnewnocystis carinii in bronchoalveolar lavage;
c) 4-fold increase in antibody titre at four weeks for Legionella,
Mycoplasma, Coxiella burneti and Chlamydia\
d) Isolation of Legionella or Mycoplasma in sputum.
The presumptive diagnosis included:
a) Isolation of the pathogen in the sputum or in various sputum
cultures;
b) The existence of compatibility in the Gram stain and sputum
culture;
c) The appearance of Legionella in the immunoflurescent test of
sputum and also in IgM titre for Chlamydia ^ 1 : 82.
The diagnosis of pneumonia by aspiration was made if the previous
history of the patient revealed aspiration, evidence of altered con-
sciousness, a diminished gag reflex or an abnormal swallowing
mechanism.
Analytical studies
A complete analysis was carried out on all patients at admission.
This included a haemogram, haemocultures, virus and mycoplasm
serology, sputum bacteriology and chest radiography. On day zero,
after fasting for 12 hours, a lipid profile study which included total
cholesterol, HDL cholesterol, apolipoproteins A, and B and triacyl-
glycerols was carried out. In addition aspartate aminotransferase,
alanine aminotransferase and γ-glutamyl transferase were also de-
termined. The lipid profiles and transaminase tests were repeated
later at 15 and 180 days. Transaminases and the lipid profile were
determined enzymatically using a Hitachi 717 multichannel ana-
lyser with Boehringer Mannheim reagents according to IFCC/
SFBC recommendations. Cholesterol was determined with an en-
zymatic colorimetric test (Cholesterol CHOD-PAP method). HDL
cholesterol was determined after precipitation of the remaining li-
poproteins by the addition of phosphotungstic acid and magnesium
ions to the sample; subsequent centrirugation leaves HDL available
for enzymatic assay (Cholesterol CHOD-PAP method). Triacyl-
glycerols were measured using a colorimetric end-point method
(GPO-PAP). Apolipoproteins Aj and B were determined by photo-
metric measurement of the antigen-antibody (ovine anti-human
apolipoproteins) reaction by the end-point method (immunoturbidi-
metric test, Tina-quant®).
Statistical analysis
The results are shown as the mean ± SD. Student's t test was used
for statistical analysis for the comparison of the mean differences
of the parametric variables, and the Mann-Whitney test was used
for non-parametric variables.
Results
The clinical features of patients with community-ac-
quired pneumonia are summarized in table 1. A defin-
Tab. 1 Clinical features of patients with community-acquired
pneumonia.























itive diagnosis was made in 14 patients, a presumptive
diagnosis in another 12 and a further 3 were diagnosed
as having pneumonia by aspiration. In the 31 remaining
patients the aetiology was unknown (tab. 2).
Changes in the lipid profile and
transaminases in the period 0 — 1 5 days
The data are summarized in table 3. Concentrations of
total cholesterol were significantly lower during the
acute process and a twenty-two percent increase of total
cholesterol can be observed from the time of admission
to the determination at 15 days (4.2 ± 1.0 vs 5.5 ± 1.3
mmol/1, p < 0.001). HDL cholesterol is significantly
lower (0.9 ± 0.4 vs 1.2 ± 0.3 mrnol/1, p < 0.001) and
an increase of 19% is seen between admission and
later analysis.
Apolipoprotein A! (0.80 ±0.25 vs 1.15 ± 0.28 g/1,
p < 0.001) and apolipoprotein B (0.77 ± 0.28 vs 0.95
± 0.28 g/l, p < 0.001) were significantly lower at ad-
mission, showing an increase of 19% and 18% for apoli-
poprotein A! and apolipoprotein B, respectively.
No significant differences were found for triacylglycer-
ols, transaminases and γ-glutamyl transferase.
Changes in lipid profile and transaminases
for the 15-180 days
The data are shown in table 3. HDL cholesterol was
significantly lower at 15 days (1.2 ± 0.3 vs 1.3 ± 0.3
mmol/1, p < 0.001). No differences were found for the
rest of the lipid variables. The values were significantly
higher at 15 days for alanine aminotransferase (35 ± 34
vs 21 ± 11 U/l, p < 0.001) and for γ-glutamyl transfer-
ase (42 ± 32 vs 34 ± 31 U/l, p < 0.001). ·
Lipid profile and transaminases in the group
with definite diagnosis
Those patients with a definite diagnosis of pneumonia
showed higher concentration of tr&cylglycerols at the
time of admission (1.9 ± 1.3 vs* 1.2 ± 0.6· mmol/1,
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(n = 31) (n = 3)
Tab. 3 Concentrations of total cholesterol, HDL cholesterol, apolipoproteins (A, and B), triacylglycer-
ols and transaminases (x ± SD) on admission (n = 60), 15 days (n = 53) and 180 days (n = 37).
Analyte Day 0 (n = 60) Day 15 (n = 53) Day 180 (n = 37)
Total cholesterol (mmol/1)








a p < 0.001 compared with sample II; d
b p < 0.01 compared with sample ΙΠ; e









p < 0.001 compared with sample
p < 0.01 compared with sample I;

































Tab. 4 Mean ± SD concentrations of total cholesterol, HDL cholesterol, apolipoproteins (Aj and B),
triacylglycerols and transaminases (χ ± SD) on admission in the group with a definite diagnosis
(n = 14) and the remaining patients (n = 46).
Definite (n = 14) Other (n = 46) Significance
Total cholesterol (mmol/1)































Tab. 5 Concentrations of total cholesterol, HDL cholesterol, apolipoproteins (Aj and B), triacylglycer-
ols and transaminases (X ± SD) at 15 days in the group with a definite diagnosis (n = 14) and the
remaining patients (n = 46).
Definite (n = 14) Other (n = 46) Significance
Total cholesterol (mmol/1)
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Tab. 6 Mean ± SD concentrations on admission of total cholesterol, HDL cholesterol, apolipoproteins
(A, and B), triacylglycerols and transaminases (x ± SD) in patients with atypical pneumonia (n = 8)
and the remaining patients (n = 52).
Total cholesterol (mmol/1)
High density lipoprotein cholesterol (mmol/1)
Triacylglycerols (mmol/1)
































p < 0.002). These differences no longer exist at 15 days.
No significant differences were found in the rest of the
lipoproteins (tabs. 4 and 5).
Table 6 shows how the significant increase of triacyl-
glycerols (1.8 ± 0.8 vs 1.3 ± 0.9 mmol/1, p < 0.01) in
patients with non-viral atypical pneumonia (Chlamydia,
Mycoplasma, Coxiella burneti) is accompanied by lower
concentrations .of HDL cholesterol (0.7 ±0.3 vs 1.0
± 0.4 mmol/1, p < 0.03).
The values of aspartate aminotransferase, alanine amino-
transferase and γ-glutamyl transferase in this group were
significantly higher.
Discussion
Community-acquired pneumonia presents a great variety
of aetiological agents. It therefore provides an opportu-
nity to study the behaviour of serum lipids in the pres-
ence of such agents. The aetiologies in our patients with
community-acquired pneumonia did not differ from
those found in previously published studies (10). In 50%
of the cases no aetiological diagnosis was made and in
the remainder the most frequent aetiology was Strepto-
coccus pneumoniae and atypical pneumonia. These find-
ings are not surprising because pathogens remain un-
identified in more than one third of patients with pneu-
monia (9).
Secondly, our results show that community-acquired
pneumonia modifies the lipid profile. We found a
marked decrease of total cholesterol, HDL cholesterol
and the apolipoproteins A! and B during the acute pro-
cess. After 15 days only the HDL cholesterol concentra-
tions was significantly increased.
Thirdly, triacylglycerols are significantly higher in the
group with a definite diagnosis. In the non-viral atypical
pneumonia group the increase of triacylglycerols is ac-
companied by a significant decrease of HDL cholesterol.
Contradictory data have been published concerning the
modifications of the lipid profile in infectious processes
(4-8). Some studies have signalled a decrease in the
concentrations of total cholesterol and HDL cholesterol
during the acute stages. Others however, have not found
variations iii serum lipids. Our findings confirm the data
of those authors reporting a decrease in these variables
during the acute process. However, we found different
ranges of values and different times to return to the base-
line value.
The concentrations of total cholesterol are similar at 15
days and at 6 months. In subjects showing a significant
decrease of HDL cholesterol during the acute phase,
however, the values were significantly higher at 6
months than at 15 days.
With reference to apolipoprotein B we found similar
data to those found by other investigators; a significant
decrease was seen during the acute process with recov-
ery at 15 days. Certain studies report that infections by
Gram-positive bacteria are characterised by decreases in
the concentrations of total cholesterol, while those infec-
tions due to Gram-negative bacteria and viruses are as-
sociated with increases of triacylglycerols (4, 11). We
found that the decrease of total cholesterol and apolipo-
proteins during the acute phase is similar in the group
of pneumonias with a definite diagnosis and in the other
pneumonias. We wish to emphasize that the concentra-
tions of triacylglycerols are significantly higher in the
group with a definite diagnosis.
Another finding worthy of mention is the decrease ob^
served in the values for HDL cholesterol during the
acute process in the subgroup of patients with non-viral
atypical pneumonia. These findings do not agree with
those previously reported by Sammalkorki et al. (7) who
found lower values of these lipoproteins in the presence
of bacterial infections and during the convalescence
phase.
The explanation of these findings is speculative. Almost
seventy percent of the patients had had fever within two
days prior to the taking of the first blood sample. The
febrile states are associated in a temporal way with a
decrease of physical activity and caloric intake, which
together with an increase of the use of energy, could be
responsible for the decrease of total pjiolesterol observed
during the acute phase. The lack of an exact daily caloric
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intake together with a lack of weight control prevented
us from delineating their explicit effects on the observed
changes. Nevertheless, similar data have been reported
in patients without caloric restriction. Other authors
have shown that the decrease of the activity of lipopro-
tein-lipase during the febrile process could be responsi-
ble for these alterations (12).
Sammelkorpi et al. (7) have reported a decrease in the
activity of lipoprotein-lipase and hepatic lipase in both
viral and bacterial infections. The decrease of HDL cho-
lesterol and the increase of the triacylglycerols found in
our investigation could be due to an alteration of lipo-
protein-lipase with a decrease in the hydrolysis of the
triacylglycerols, given the known predisposition of aeti-
ological agents of atypical pneumonia in producing ex-
trapulmonary lesions (13, 14). However, we cannot re-
late the increase of transaminases seen in this group to
a reduction in the activity of hepatic lipase, because this
would have an inverse and different effect from that ob-
served for the HDL cholesterol values.
It is clear from other work that cytokines, such as tu-
mour necrosis factor (TNF), also increase hepatic lipid
synthesis. Thus, increases in lipoprotein production, as
well as decreased removal, could contribute to the ob-
served changes (15).
We conclude that a pneumonic process is accompanied
by a significant decrease in the concentrations of total
cholesterol, HDL cholesterol and apolipoproteins A! and
B. The decrease of HDL cholesterol persists after 15
days. Patients with non-viral atypical pneumonia present
a peculiar picture. Since they display elevated values for
liver quantities and triacylglycerols, as well as reduced
HDL cholesterol, it would be very interesting to deter-
mine interleukin, LPL and TNF in members of this
group.
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